Densitas supports value-based care through advanced healthcare analytics powered by AI at the patient, clinic, and system levels. Its solutions provide on-demand insights for tailored risk-based management of patients and enable healthcare administrators to monitor clinical, quality, and operational performance indicators. The platform is designed to be PACS-centric by operating on the routinely archived standard DICOM images that radiologists review and supports point-of-care and retrospective processing of mammograms. Densitas was founded in 2011 and is based in Halifax, Canada.
Missing: Densitas's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Densitas's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Densitas
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Densitas is included in 7 Expert Collections, including Women's Health & Wellness.
Women's Health & Wellness
Startups focused on providing products and services catering to women's health and wellbeing.
Value-Based Care & Population Health
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Health Monitoring & Diagnostics
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Densitas has filed 2 patents.
Breast cancer, Image processing, Medical imaging, Feature detection (computer vision), Breast
Breast cancer, Image processing, Medical imaging, Feature detection (computer vision), Breast
Latest Densitas News
Nov 28, 2022
News provided by Share this article Share this article The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows HALIFAX, NS, Nov. 28, 2022 /PRNewswire/ - Densitas® Inc., a global provider of AI solutions for digital mammography and breast screening, today announced that it has connected to the Nuance Precision Imaging Network™ (PIN), a secure nationwide cloud platform empowering collaborative care teams with streamlined communications and workflow-integrated AI insights from diagnostic imaging to improve healthcare outcomes and costs. Densitas® intelliMammo™ , comprising intelliMammo™ densityAI™, qualityAI™, and riskAI™, offers a FDA/ACR compliant solution for clinical and enterprise decision-making that includes breast density, breast cancer risk, and clinical image quality. IntelliMammo™ presents clinical care teams with on-demand actionable information and digitized workflows to systematically improve mammography quality, organizational and workflow efficiencies, and support early breast cancer detection and treatment. Leveraging the nationwide scale of the Nuance PowerScribe and Nuance PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network connects radiologists, providers, health plans, self-insured employers, life science companies, and other imaging stakeholders to broaden access to precision diagnostics and therapeutics, increase healthcare efficiency, and lower costs. It enables secure and seamless sharing of AI insights from diagnostic imaging to enhance clinical decision-making, enhance care team collaboration, and facilitate the earlier detection and treatment of diseases for improved patient outcomes. "Our intelliMammo™ platform provides a solid foundation for population health management as patients navigate through breast cancer screening, diagnostic, treatment, and prevention pathways," said Mo Abdolell, CEO, of Densitas. "Through the Nuance Precision Imaging Network, intelliMammo™ becomes immediately accessible to over 10,000 healthcare facilities across the US. The addition of intelliMammo™ opens the door to Nuance customers to capture information from routine screening mammograms and seamlessly leverage patient-centered data and insights in their existing clinical and administrative workflows." "We're proud to support Densitas® with seamless workflow-integrated access through the Nuance Precision Imaging Network, providing powerful clinical decision support tools at the point-of-care as they advance their important work in breast cancer screening," said Roland Dias, Vice President, Precision Imaging Network, Nuance. About Densitas® Densitas® is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health. Densitas® designs intuitive solutions that boost the ability of hospitals and imaging centers that perform mammography to improve efficiencies, meet FDA/ACR compliance requirements, and support early breast cancer detection and treatment. For more information, visit www.densitashealth.com SOURCE Densitas Inc.
Densitas Frequently Asked Questions (FAQ)
When was Densitas founded?
Densitas was founded in 2011.
Where is Densitas's headquarters?
Densitas's headquarters is located at 1344 Summer Street, Halifax.
What is Densitas's latest funding round?
Densitas's latest funding round is Seed.
How much did Densitas raise?
Densitas raised a total of $360K.
Who are the investors of Densitas?
Investors of Densitas include Medteq, JLabs, Rogers Venture Partners and Innovacorp.
Who are Densitas's competitors?
Competitors of Densitas include Ferrum Health, Clearsense, PaySpan, Ibex Medical Analytics, Navvis, ArborMetrix, Upfront Healthcare, ClosedLoop.ai, RevOps Health, Thynk Health and 123 more.
Compare Densitas to Competitors
ClosedLoop is healthcare's data science platform. It make it easy for healthcare organizations to use AI to improve outcomes and reduce costs. Purpose-built for healthcare, ClosedLoop combines an intuitive end-to-end machine learning platform with a comprehensive library of healthcare-specific features and model templates. Customers use the Explainable AI to drive clinical excellence, operational efficiency, value-based contracts, and enhanced revenue. The company was founded in 2017 and is based in Austin, Texas.
Ferrum Health develops developed an Enterprise Artificial Intelligence (AI) deployment platform to improve patient outcomes by democratizing health systems' access to clinical AI-integrated technologies worldwide. The company runs quality assurance algorithms on patient data generated across health systems to detect opportunities to close gaps across the continuum of care. Ferrum Health was founded in 2017 and is based in Sunnyvale, California.
Thynk Health optimizes data-driven workflows and provides operational and clinical analytics for lung cancer screening programs and other quality initiatives. The company was founded in 2014 and is based in Lexington, Kentucky.
Ambient Clinical Analytics makes software tools that support hospital emergency rooms and intensive care units. It sells healthcare data assimilation, communication, and analytics-based decision support tools that support the ICU, Operating Room and Emergency Department. Its business model is supported by software license fees, SaaS, Cloud and system integration revenue.
Lightbeam Health Solutions delivers a revolutionary model for managing patient populations and associated risk. Lightbeam's vision is to bring health data into the light through the use of analytics, and to provide the insight and capabilities healthcare clients need to ensure patients receive the right care at the right time. Lightbeam's platform facilitates end-to-end population health management for ACOs, Payers, Large Provider Groups, Health Systems and other healthcare organizations aspiring to provide superior care at a lower cost.
Dorsata provides a software platform that allows clinicians to improve collaboration and review clinical care pathways. Over 1500 clinicians already use the software every day to reduce the amount of time spent doing tasks like documentation and data entry – thereby freeing them up to focus on patients.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.